Open Meeting Announcement - Multiple MolDX Policies MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis and MolDX: Genetic Testing for Heritable Thoracic Aortic Disease - October 10, 2024

Date Posted: August 29, 2024

This article has been published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301(OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Noridian Healthcare Solutions will be hosting an Open Public Meeting on Thursday, October 10, 2024, from 1 p.m. to 3 p.m. CT.

Advance Registration is required.

  • Registration deadline to present comments on an LCD will close on October 3, 2024, at 11:59 pm CDT.
  • General Registration deadline to participate by listen-only mode will close on October 9, 2024, at 11:59 pm CDT.

Proposed Local Coverage Determination (LCDs) and Local Coverage Article (LCAs)

  • MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis DL39950
  • Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis DA59874
  • MolDX: Genetic Testing for Heritable Thoracic Aortic Disease DL39946
  • Billing and Coding: MolDX: Genetic Testing for Heritable Thoracic Aortic Disease DA59870
  • View meeting details and register now from the MolDX Open Public Meeting  webpage.
Last Updated Aug 29 , 2024